- Home
- PSIG vs BIAF Comparison
PSIG vs BIAF Comparison
Compare PSIG & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIG
- BIAF
- Stock Information
- Founded
- PSIG 1993
- BIAF 2014
- Country
- PSIG Hong Kong
- BIAF United States
- Employees
- PSIG N/A
- BIAF N/A
- Industry
- PSIG
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PSIG
- BIAF Health Care
- Exchange
- PSIG NYSE
- BIAF Nasdaq
- Market Cap
- PSIG 10.9M
- BIAF 12.2M
- IPO Year
- PSIG N/A
- BIAF 2022
- Fundamental
- Price
- PSIG $0.45
- BIAF $0.29
- Analyst Decision
- PSIG
- BIAF Hold
- Analyst Count
- PSIG 0
- BIAF 1
- Target Price
- PSIG N/A
- BIAF N/A
- AVG Volume (30 Days)
- PSIG 105.6K
- BIAF 12.3M
- Earning Date
- PSIG 07-21-2025
- BIAF 08-13-2025
- Dividend Yield
- PSIG N/A
- BIAF N/A
- EPS Growth
- PSIG N/A
- BIAF N/A
- EPS
- PSIG N/A
- BIAF N/A
- Revenue
- PSIG $87,166,469.00
- BIAF $8,809,228.00
- Revenue This Year
- PSIG N/A
- BIAF N/A
- Revenue Next Year
- PSIG N/A
- BIAF $20.00
- P/E Ratio
- PSIG N/A
- BIAF N/A
- Revenue Growth
- PSIG N/A
- BIAF 78.40
- 52 Week Low
- PSIG $0.27
- BIAF $0.16
- 52 Week High
- PSIG $4.20
- BIAF $2.99
- Technical
- Relative Strength Index (RSI)
- PSIG N/A
- BIAF 49.68
- Support Level
- PSIG N/A
- BIAF $0.26
- Resistance Level
- PSIG N/A
- BIAF $0.35
- Average True Range (ATR)
- PSIG 0.00
- BIAF 0.06
- MACD
- PSIG 0.00
- BIAF 0.00
- Stochastic Oscillator
- PSIG 0.00
- BIAF 25.07
About PSIG PS INTERNATIONAL GROUP LTD
PS International Group Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports, and local transportation and warehousing-related services such as repackaging, labeling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing to meet the requirement of customers.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.